By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Acetylon Pharmaceuticals 

Seaport Center
70 Fargo Street, Suite 205
Boston  Massachusetts  02210  U.S.A.
Phone: 617-245-1300 Fax: 617-245-1301


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Acetylon Announces Upcoming Scientific Presentations On The Use Of Selective HDAC Inhibitors In Treating Genetic Blood Disorders And Cancers 12/2/2016 9:56:51 AM
Celgene (CELG) Passes on Option-to-Buy $600 Million Deal for Boston's Acetylon 8/8/2016 7:21:21 AM
Acetylon Pharmaceuticals Presents Data On The Use Of HDAC6 Inhibitors Ricolinostat (ACY-1215) And ACY-241 In Combination With Pomalidomide And Dexamethasone For The Treatment Of Multiple Myeloma 6/13/2016 9:58:23 AM
ASCO2016: Acetylon Pharmaceuticals Collaborators Publish ASCO Abstracts Demonstrating Immunomodulatory Properties Of Ricolinostat In Preclinical Melanoma Models 6/3/2016 11:52:38 AM
Acetylon Pharmaceuticals Publishes New Mechanism For The Treatment Of Sickle Cell Disease/Beta-Thalassemia With Selective HDAC1/2 Inhibition In Plos One 5/4/2016 8:29:09 AM
Acetylon Pharmaceuticals Announces The Presentation Of Preclinical Data At AACR Supporting The Use Of Selective HDAC6 Inhibition To Modulate Chronic Lymphocytic Leukemia (CLL) Immunobiology 4/20/2016 11:32:03 AM
Acetylon Pharmaceuticals Presents Data From Three Phase Ib Studies Of Ricolinostat (ACY-1215) For The Treatment Of Lymphoma And Multiple Myeloma 12/7/2015 10:36:02 AM
Acetylon Pharmaceuticals Presents Data On The Use Of HDAC 6 Inhibitors Ricolinostat (ACY-1215) And ACY-241 In Combination With Pomalidomide For The Treatment Of Multiple Myeloma 12/7/2015 10:18:33 AM
Acetylon Pharmaceuticals Presents Data On The Pharmacokinetics And Hbe/Hbg Hemoglobin Induction Following Once Daily Dosing Of An Oral HDAC1,2 Inhibitor In Animal Models 12/7/2015 10:17:20 AM
Acetylon Pharmaceuticals’s Oral Selective HDAC6 Inhibitor ACY-241 Enhances Anti-Tumor Activity Of Paclitaxel In Preclinical Solid Tumor Models 11/6/2015 8:10:15 AM
12345
//-->